Wells Fargo & Company I Bio, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $160.0 $2 - $1,760	-11 Reduced 0.53%	2,049 $0
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.46 $29,349 - $58,699	-127,608 Reduced 98.41%	2,060 $0
Q1 2022 May 16, 2022	BUY	$0.3 - $0.61 $2,661 - $5,410	8,870 Added 7.34%	129,668 $55,000
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $65,984 - $124,769	119,971 Added 14506.77%	120,798 $66,000
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $3,039 - $4,357	-2,867 Reduced 77.61%	827 $1,000
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $77,831 - $105,263	-63,796 Reduced 94.53%	3,694 $6,000
Q1 2021 May 13, 2021	SELL	$1.18 - $2.62 $272,025 - $603,988	-230,530 Reduced 77.35%	67,490 $104,000
Q4 2020 Feb 09, 2021	BUY	$1.05 - $2.24 $136,555 - $291,318	130,053 Added 77.43%	298,020 $314,000
Q3 2020 Nov 05, 2020	BUY	$1.7 - $6.41 $80,743 - $304,449	47,496 Added 39.43%	167,967 $341,000
Q2 2020 Aug 13, 2020	BUY	$0.87 - $2.46 $104,002 - $294,075	119,543 Added 12881.79%	120,471 $268,000
Q1 2020 May 14, 2020	BUY	$0.22 - $2.45 $204 - $2,273	928 New	928 $1,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.7M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.